pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 29·1 min read
save

NSF launches $47 million pilot to create joint university-industry Ph.D. programs for life scientists

Jul 29, 2026·read at STAT ↗Positive

The National Science Foundation, with funding announced by the Trump administration, is testing a new Ph.D. training model that blends academic study with industry experience.

The $47 million pilot will support four‑year Ph.D. programs jointly funded by universities and industry partners, requiring participants to spend at least one year conducting research at a company site.

Around 30 university‑industry pairs plan to take part, including the University of California‑San Diego, Northwestern, Purdue and Columbia, alongside companies such as Agilent Technologies, DuPont and Bayer Crop Science.

The effort responds to a growing trend of early‑career scientists leaving academia and aims to broaden career pathways in the life‑science sector.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “NSF testing new Ph.D. model giving trainees academic and industry experience”

read at STAT ↗
1,140 words · retrieved Jul 29
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AGILENT TECHNOLOGIES, INC.2LEADINGLILLYRISING
drugs
JOURNAVXsuzetrigine
topics
OphthalmologyPain

related stories

  • May 12A year after Vertex’s big launch, pain drug research faces a pivotal momentBioPharma Dive
  • Aug 4Latigo laces up for $247M IPO to fund non-opioid pain drug rival to Vertex’s JournavxFierce Biotech
  • Jul 20Pain drugmaker Latigo outlines plans to go publicBioPharma Dive
  • 17h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Aug 19Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: AnalystsBioSpace